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Summary
CONTEXT: Physical health is generally poorer in patients 
with mental illness than in the general population. Cardio-
vascular diseases linked to metabolic syndrome are the 
principle issue encountered by these patients. The four-
factor M-BACK questionnaire was developed in Australia 
to measure the barriers, attitudes, confidence and knowl-
edge of health staff in relation to metabolic syndrome. The 
goal of this study was to assess the psychometric proper-
ties of the French translation of the M-Back questionnaire.
METHODS: The French M-Back was completed online
by 137 mental health professionals. Internal validity was
assessed using Bayesian structural equation modelling,
which is halfway between exploratory and confirmatory
factor analysis. Concurrent validity was estimated by
studying the relationship between the M-Back scores and
several important socio-professional variables.
RESULTS: The four-factor model showed good fit to the
data. Two items had significant cross-loadings on other
dimensions. Hypothesised relationships between M-back
scores and socio-professional variables were confirmed.
CONCLUSION: The French M-Back is a valid tool to mea-
sure the barriers, attitudes, confidence and knowledge of
health staff in relation to metabolic syndrome and could
be used to identify training needs in this domain among
health professionals.
Introduction
Physical health is known to be poorer in patients with men-
tal illness than in the general population [1]. Furthermore,
mortality rates are higher in people with serious mental
illness such as schizophrenia, bipolar disorder and ma-
jor depressive disorder [2, 3]. This is predominantly be-
cause of a higher prevalence of physical comorbidities
such as cardiovascular diseases. Patients suffering from
a serious mental illness tend to have a higher probability
of meeting the criteria for metabolic syndrome [4], such
as insulin resistance, high blood pressure, high levels of
blood triglycerides, low levels of high-density lipoprotein
cholesterol and/or abdominal obesity. In addition to this,
people with serious mental illness have higher rates of
smoking and obesity while having lower levels of physical
activity compared with the general population [5, 6]. It is
has also long been known that antipsychotic drugs have
several side effects contributing to cardiovascular disease
[7].They can lead to hyperlipidaemia [8], glucose dysregu-
lation [9], and induction of weight gain through increased
appetite and food intake [10]. It is therefore essential to
take care of physical health in patients with serious men-
tal illness and hence to propose appropriate training of the
mental health staff in order for them to promote strategies
that minimise the risk to develop metabolic syndrome.
The 16 items M-BACK questionnaire was developed to
evaluate the impact of specialised training in metabolic
health care for mental health nurses [11]. As higher mortal-
ity rates in patients with serious mental illness are strongly
linked to poorer physical health [1–3], it was deemed im-
portant to assess if mental health workers felt capable of
implementing the strategies that have been developed to
prevent metabolic syndrome among patients with serious
mental illness. The tool content and its effectiveness in
evaluating training and education on the approach of meta-
bolic health care by mental health clinicians were validated
in English [11] in a study including mental health nurses,
psychiatrists and psychologists, in order to explore this is-
sue among the main professional groups involved in men-
tal health care.
The aim of our study was to translate the questionnaire into
French and verify its psychometric properties.
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Participants were recruited through an online questionnaire
sent by e-mail to all employee of the general psychiatry
service (n = 225). A total of 137 (61%) French-speaking
mental health professionals participated in the study. Par-
ticipants were informed about the study and those interest-
ed in participating could complete anonymously the online
questionnaire. An e-mail reminder was sent 1 week later to
motivate professionals who had not yet have filled in the
questionnaire.
Measures
Information about age, gender, years of experience, occu-
pation, managerial role, previous work experience in so-
matic medicine, metabolic syndrome training, training on
specific health problems encountered by psychiatric pa-
tients, previous experience with metabolic syndrome, pre-
vious experience of referral to a specialist for metabolic
syndrome and awareness that antipsychotics could increase
blood glucose levels were self-reported with multiple
choice questions in the initial part of the online question-
naire.
French version of the M-Back
The content of the original M-back questionnaire stemmed
from a literature review and that was refined by an expert
review panel and validated via a piloting process [11].
Test-retest reliability was satisfactory for all four scores.
The M-BACK questionnaire is composed of 16 items, sep-
arated in 4 domains related to metabolic syndrome (knowl-
edge, confidence, attitudes and practice barriers in relation
to metabolic health), each of them scored on a five-point
Likert scale ranging from 'strongly disagree' (scoring 1) to
'strongly agree' (scoring 5). Barriers items (1–4) address
various elements that professionals may evoke as hin-
drance to metabolic screening and intervention, including
workload, service user interest, conflict with mental health
goals and inability to effect change. Attitudes items (5–8)
investigate attitudes regarding metabolic monitoring, the
provision of advice regarding smoking cessation, physical
activity and nutritional intake. Confidence items (9–12) as-
sess the confidence of respondents in providing interven-
tions to prevent or treat metabolic syndrome, including
smoking cessation, physical activity and nutritional inter-
ventions. Knowledge items (13–16) assess knowledge
about metabolic health, screening, interpreting pathology
reports and understanding of the metabolic side effects of
antipsychotic medication. The English version of the M-
Back questionnaire was translated independently by two
persons working in the medical field who are native French
speakers and fluent in English; discrepancies were dis-
cussed in order to produce a consensus version. The items
of the French version are presented in Table 1.
Procedure
In order to assess the internal validity of the French-lan-
guage M-Back scores, we tested the original four-factor M-
Back model. In order to estimate the concurrent validity,
we examined the relationship between M-Back scores and
socio-professional variables. We hypothesised that having
a senior role, having previously worked in somatic med-
icine, work experience and training would be related to
higher scores on the knowledge, attitude and confidence
dimensions, and lower scores on the barriers dimension.
Ethics approval and consent to participate
Written informed consent was obtained from all partici-
pants and all methods were carried out in accordance with
the recommendations of the Declaration of Helsinki.
Statistical analysis
Internal validity
Internal validity was estimated using Bayesian structural
equation modelling (BSEM) [12]. More precisely, we
wanted to estimate factor loadings between the 16 items
and the 4 dimensions taking into account the expected
loadings, namely between items 1–4 and barriers, items
5–8 and attitudes, items 9–12 and confidence, and items
Table 1:
French version of the M-Back.
No. Items Dimension
1 Ma charge de travail m'empêche de faire des activités de promotion de santé avec les patients. Barrières
2 Les patients atteints d'une maladie mentale grave ne souhaitent pas améliorer leur santé physique. Barrières
3 Informer les patients sur les effets que les médicaments pourraient avoir sur leur santé physique augmenterait la non-adhérence. Barrières
4 Le dépistage du syndrome métabolique et les interventions de santé physique inutiles puisque de mauvais résultats en terme de santé physique sont in-
évitables.
Barrières
5 Le dépistage de la santé métabolique est une partie importante de mon rôle de médecin en santé mentale. Attitudes
6 Donner des conseils pour arrêter de fumer est une partie importante de mon rôle en tant que médecin en santé mentale. Attitudes
7 Encourager les patients à augmenter leur taux d'activité physique est une partie importante de mon rôle de médecin en santé mentale. Attitudes
8 Discuter de l'apport nutritionnel est une partie importante de mon rôle en tant que médecin en santé mentale. Attitudes
9 J’ai confiance en ma capacité à dépister le syndrome métabolique. Confiance
10 Je suis confiant dans le fournissement de conseils de sevrage tabagique aux patients. Confiance
11 Je suis confiant dans la prescription d'interventions physiques pour prévenir / traiter le syndrome métabolique. Confiance
12 Je suis confiant dans l'utilisation d'interventions alimentaires pour prévenir / traiter le syndrome métabolique chez les patients. Confiance
13 J'ai une bonne connaissance du syndrome métabolique. Connaissances
14 Je comprends comment dépister le syndrome métabolique. Connaissances
15 Je comprends comment lire les rapports de pathologie pour les résultats des lipides et du glucose. Connaissances
16 Je comprends les profils des effets secondaires métaboliques des différents médicaments neuroleptiques. Connaissances
Note: Je ne suis pas du tout d’accord = 1; Je ne suis pas d'accord = 2; Neutre = 3; Je suis d'accord = 4; Je suis entièrement d'accord = 5.
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13–16 and knowledge. With classical confirmatory factor
analysis, almost all cross loadings between latent variables
and measures are fixed to zero in order to allow the model
to be identified [13, 14]. However, inappropriate zero
cross-loadings can contribute to poor model fit, distorted
factors and biased factor correlations; most importantly,
they do not necessarily faithfully reflect theory because
small but nonzero cross-loadings could be equally com-
patible with theory [12]. BSEM estimation combines prior
distributions (i.e., what we expect before conducting the
study) for parameters with new collected data (the new
study data) and forms posterior distributions (what we ul-
timately believe after taking the new data into account and
combining it with our prior beliefs) for parameters through
the Bayes theorem. We used diffuse non-informative priors
with a zero mean and an infinite variance for the expect-
ed loadings and Informative priors with a zero mean and a
small variance (0.05) for the unexpected loadings ('cross-
loadings'). Correlations between residuals were also esti-
mated in order to gain potential insight on the measure-
ment model [15, 16]. For that purpose a prior with a zero
mean and a small variance (an inverse-Wishart distribu-
tion with 100 degrees of freedom) was chosen. Globally,
BSEM is halfway between exploratory and confirmatory
factor analysis because all relationships between items and
dimensions were estimated and a priori knowledge was in-
corporated. BSEM has a better performance on small sam-
ple sizes because it does not rely on asymptotic large-sam-
ple normality of the estimates [17, 18].
Items were considered categorical ordinal and model esti-
mation was performed using three chains with 50,000 it-
erations. The first half of the chains were discarded as a
burn-in phase, and the second half was used to estimate
the posterior distribution. Convergence was monitored us-
ing the potential scale reduction (PSR) criterion (<1.05)
and model fit was assessed with the posterior predictive p-
value (PPP), where a value close to 0.5 indicates a good
fit [12]. Parameters were considered to be significant when
the 95% credibility interval of the parameter did not cover
zero.
Concurrent validity
The relationships between the M-back scores and socio-
professional variables were estimated. For the type of
training, three groups were compared, namely medical
doctors, nurses and others (which included caregivers, di-
etitians, physiotherapist, psychologists, educators, anima-
tor, and occupational therapists). Sex, age and number of
years of professional experience were also compared. Fur-
thermore, we explored if having the role of senior doctor,
having previously worked in somatic medicine, being pre-
viously trained on the metabolic syndrome or on health
problems encountered by psychiatric patients led to differ-
ent scores. We also explored if the knowledge that antipsy-
chotics can increase blood glucose would have an impact
on the four dimensions and if people who were able to ob-
serve this phenomenon would have scores different from
those who had never encountered such kind of problem.
Lastly, we wanted to know if the fact of having referred a
patient to a specialist for metabolic syndrome in the past
would lead to different results.
Nominal variables were used to define groups and either
t-test or analysis of variance (ANOVA) were used to com-
pare the M-Back scores. For continuous variables we used




The model fit was good (PPP = 0.545). The factor loadings
of the M-Back are presented in table 2. All expected load-
ings were successfully backed-up by the data. Two addi-
tional cross-loadings were detected (items 5 and item 9
loaded on their respective factor and on the knowledge
factor as well). For this reason, we included a modified
knowledge score (referred to as knowledge score 2) with
these two additional items for the concurrent validity
analysis.
Factor correlations indicated that the barriers factor was
independent of the three other dimensions. The three re-
maining factors were positively correlated with each other.
No correlation between error terms was detected, indicat-
ing correlations between items could be solely accounted
for by the four factors.
Concurrent validity
All results are summarised in table 3. Age was negatively
correlated with barriers (r = –0.228, p = 0.015) and pos-
itively correlated with confidence (r = 0.238, p = 0.012)
and knowledge (score 1: r = 0.215, p = 0.022; score 2: r =
0.233, p = 0.013). Analysis revealed no significant differ-
ence regarding gender for any of the four M-back dimen-
sions.
Years of experience were negatively correlated with bar-
riers (r = –0.329, p <0.001) and positively correlated with
confidence (r = 0.221, p = 0.011). The knowledge scores
were the only ones to differ across professions. Scores
were higher for physicians and nurses (score 1: F(2,130) =
35.286, p <0.001, difference between physicians and other
occupation d = 1.88; difference between nurses and other
occupations d = 1.20; score 2: F(2,130) = 30.124,
p <0.001, difference between physicians and other occupa-
tion d = 1.71; difference between nurses and other occupa-
tions d = 1.11).
Managerial role was related to lower barriers scores
(t(135) = 3.823, p <0.001, d = 0.74) and higher knowledge
scores (score 1: t(135) = –1.998, p = 0.048, d = 0.36; score
2: t(135) = –2.203, p = 0.029, d = 0.40).
Previous work experience in somatic medicine was related
to higher confidence (t(133) = –2.660, p = 0.009, d = 0.46)
and higher knowledge (score 1: t(135) = –4.045, p <0.001,
d = 0.70; score 2: t(135) = –4.126, p <0.001, d = 0.71).
Metabolic syndrome training was related to less barriers
(t(135) = 2.231, p = 0.027, d = 0.38), more confidence
(t(133) = –2.865, p = 0.005, d = 0.51) and higher knowl-
edge (score 1: t(135) = –4.608, p <0.001, d = 0.83; score 2:
t(135) = –4.700, p <0.001, d = 0.85).
Training on specific health problems encountered by psy-
chiatric patients was related to less barriers (t(134) =
3.020, p = 0.003, d = 0.52) and higher knowledge (score1:
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Table 2:
Factor loadings and factor correlations of the French M-Back.
Loadings (median) Barriers Attitudes Confidence Knowledge
CI 95% CI 95% CI 95% CI 95%
Item 1 {0.430} 0.041 -0.047 0.014
0.294 0.630 -0.151 0.241 -0.275 0.167 -0.321 0.363
Item 2 {0.762} -0.038 -0.004 0.101
0.390 1.013 -0.238 0.133 -0.201 0.188 -0.344 0.558
Item 3 {0.463} 0.023 0.069 -0.097
0.137 0.797 -0.172 0.219 -0.143 0.299 -0.437 0.301
Item 4 {0.411} -0.008 0.008 -0.296
0.059 0.763 -0.202 0.178 -0.202 0.213 -0.603 0.101
Item 5 -0.061 {0.485} -0.051 0.319
-0.215 0.070 0.347 0.657 -0.239 0.121 0.070 0.552
Item 6 0.002 {0.786} 0.016 0.007
-0.115 0.120 0.591 0.985 -0.143 0.181 -0.278 0.280
Item 7 0.03 {0.876} -0.014 -0.042
-0.105 0.110 0.700 0.983 -0.167 0.131 -0.342 0.238
Item 8 0.004 {0.857} 0.047 -0.036
-0.096 0.108 0.674 1.036 -0.083 0.207 -0.321 0.237
Item 9 0.010 0.003 {0.307} 0.658
-0.084 0.101 -0.107 0.115 0.192 0.478 0.463 0.811
Item 10 -0.034 -0.006 {0.718} -0.112
-0.183 0.103 -0.186 0.172 0.423 1.042 -0.485 0.206
Item 11 0.003 0.013 {0.776} -0.142
-0.135 0.138 -0.162 0.185 0.484 1.089 -0.516 0.182
Item 12 0.014 0.041 {0.859} -0.099
-0.098 0.133 -0.104 0.206 0.585 1.135 -0.458 0.237
Item 13 0.001 -0.040 0.038 {0.879}
-0.091 0.093 -0.157 0.067 -0.077 0.172 0.760 0.981
Item 14 0.002 0.002 0.003 {0.929}
-0.073 0.078 -0.090 0.100 -0.092 0.113 0.814 1.011
Item 15 0.012 0.032 0.060 {0.752}
-0.101 0.130 -0.098 0.171 -0.082 0.230 0.570 0.897
Item 16 -0.058 0.052 -0.085 {0.716}
-0.201 0.070 -0.098 0.211 -0.275 0.080 0.523 0.898
Factor correlations




Confidences -0.076 0.570 –
-0.502 0.403 0.294 0.758
Knowledge -0.287 0.424 0.610 –
-0.733 0.376 0.074 0.672 0.236 0.819
Loadings in curly brackets were freely estimated. Other loadings were estimated with approximate zero priors. Loadings in bold are considered significant; CI = credibility interval.
Table 3:
Relationship between the M-Back scores and socio-professional variables.
Barriers Attitudes Confidence Knowledge (both scores)
Age – + +
Gender
Years of experience – +
Occupation other than physician or nurse –
Managerial role + +
Previous work experience in somatic medicine + +
Metabolic syndrome training – + +
Training on specific health problems encountered by psychiatric patients – +
Previous experience with metabolic syndrome +
Previous experience of referral to a specialist for metabolic syndrome + + +
Awareness that antipsychotics increase blood glucose levels + + +
Note: – negative relationship; + positive relationship.
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t(134) = –3.766, p <0.001, d = 0.65; score 2:
t(134) = –3.484, p = 0.001, d = 0.60).
Previous experience with metabolic syndrome was related
to higher knowledge (score 1: t(122.457) = –4.004,
p <0.001, d = 0.69; score 2: t(135) = –3.841, p <0.001, d =
0.65).
Previous experience of referral to a specialist for metabolic
syndrome was related to higher attitude (t(134) = –2.303,
p = 0.023, d = 0.41), higher confidence (t(133) = –2.271,
p = 0.025, d = 0.40) and higher knowledge (score 1:
t(135) = –4.033, p <0.001, d = 0.71; score 2:
t(135) = –4.449, p <0.001, d = 0.78).
Finally, awareness that antipsychotics can increase blood
glucose levels was related to higher attitude (t(134) =
2.476, p = 0.015, d = 0.21), higher confidence (t(133) =
2.132, p = 0.035, d = 0.24) and higher knowledge (score1:
t(135) = 5.913, p <0.001, d = 1.11; score 2: t(135) = 5.867,
p <0.001, d = 1.10).
Discussion
On the basis of this research, the French version of the M-
Back is validated. Our results showed that the four-factor
French version of the M-Back is adequate and similar to
the original English version. In addition, we found that M-
Back scores differed between professions, which is to be
expected given the different roles of these professionals.
These differences suggest that the training needs regarding
metabolic syndrome may vary depending on profession.
The more professionals are advanced in their practice, the
more likely they appear to be able to promote prevention
and to deal with metabolic syndrome issues, suggesting a
greater training effort should be made during undergradu-
ate training and the early years of professional practice in
order to minimise this delay.
The four-factor model showed good fit to the data. Two
items had significant cross-loadings on the knowledge la-
tent variable. In other words, one attitude item and one
confidence item were likely to be influenced by knowledge
as well. That is why we included these two items in a six-
item variation of the knowledge score. Nevertheless, the
two scores yielded a very similar pattern of results with
regard to concurrent validity and relationship with profes-
sional variables. For the sake of simplicity, the usage of
the original fouritem scale rather than the sixitem alterna-
tive appears reasonable. Deleting those two items also ap-
peared to be a poor alternative, given that the attitude and
confidence scores would be less reliable with only three
items. Barriers were not correlated to other dimensions,
suggesting these items may be context dependant. Atti-
tude, knowledge and confidence were positively correlat-
ed, which suggests training and knowledge are linked to
higher confidence regarding capacity to promote strategies
to mitigate the risk of metabolic syndrome.
Our hypotheses regarding potential relationships between
M-back scores and socio-professional variables were con-
firmed and some important points emerged from the analy-
sis of the results in this regard. The profession of medical
doctor seems to lead to higher knowledge about metabolic
syndrome as compared with nurses and other professions,
and this is enhanced in senior doctors or in those who have
previously worked in somatic medicine. As the higher feel-
ing of knowledge and confidence were also found in older
subjects and in individuals with more years of profession-
al experience, in those who received training on metabol-
ic syndrome or on health problems encountered by psychi-
atric patients, or in those who have knowledge of the side
effects of antipsychotic drugs, it seems important to train
people on all these subjects earlier in their careers in order
to minimise delay in providing good treatment to patients.
Moreover, those who have a good knowledge of the prob-
lem will also have a tendency to send the patient to a spe-
cialist because of their ability to recognise their limits and
the importance of the problem. Lastly, and quite intuitive-
ly, those who have already observed the phenomenon have
higher knowledge about the subject, or at least have this
feeling.
Our study has some limitations. Firstly, the sample size
was moderate and it has been shown that sample sizes be-
low 100 to 150 could lead to increased over-rejection rates
for indices of goodness of fit [19, 20]. This was one moti-
vation to use the BSEM approach, which has a better per-
formance with small sample sizes. In the present study,
the hypothesised four-factor structure was well recovered
and goodness of fit was good, which increases the confi-
dence we have in our results. Secondly, regarding the com-
parison between professions, medical doctors constituted a
small number of individuals and the group of others was
heterogeneous. However, nurses and medical doctors were
both homogeneous groups and results were therefore quite
representative. Thirdly, it is possible that people with less
knowledge regarding this issue may have been less inter-
ested in answering the questionnaire. Fourthly, although
the M-Back was translated and discussed by two profes-
sionals, an additional expert committee to review and fi-
nalise the translation was not involved. Fifth, additional
and larger studies are needed to disentangle the contribu-
tions of occupational differences and years of experience
more thoroughly. Lastly, competences regarding metabolic
syndrome were self-evaluated, and scores may not reflect
to the actual level of knowledge participants had in this do-
main.
Conclusions
This study validated the French version of the M-Back
questionnaire. Our results suggest that the French M-Back
is a valid tool to measure the barriers, attitudes, confidence
and knowledge of health staff regarding metabolic syn-
drome and that it could be used to identify training needs
about this subject among health professionals. The in-
crease in knowledge and confidence with years of practice
and its dependence on type of profession suggest that a
particular effort should be made to provide training to all
professions and to do so early in their careers in order to
maximise chances of patients being well taken care of in
this regard. Because of the amount of time they spend with
patients, nurses stand out as a group where such early and
intensive training might have the most impact on patient
care.
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